Vinci Pharmaceuticals is a health care company that treats retinal diseases.
Vinci Pharmaceuticals has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
Vinci Pharmaceuticals's investors include Dynagrow Capital, MintPharma Capital, Third Seven Capital.
Vinci Pharmaceuticals is headquartered in Avon By The Sea, United States.
Vinci Pharmaceuticals is a health care company that treats retinal diseases.
Vinci Pharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vinci Pharmaceuticals — Funding & Investors." VCBacked, October 8, 2026, https://www.vcbacked.co/company/vinci-pharmaceuticals. Accessed November 2, 2026.
VCBacked. (2026). Vinci Pharmaceuticals — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/vinci-pharmaceuticals
{{cite web |title=Vinci Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/vinci-pharmaceuticals |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated